跨导管大动脉置换后心房动的抗凝疗法:国家数据库洞察力
Koki Takegawa1,2, Koshiro Kanaoka1,3, Yoshitaka Iwanaga4
1Department of Medical and Health Information Management National Cerebral and Cardiovascular Center Osaka Japan.
Journal of the American Heart Association
|June 24, 2025
概括
直接口服抗凝剂 (DOACs) 对于经过透气管大动脉置换 (TAVR) 后心房动 (AF) 的患者来说,比维生素K对抗剂 (VKA) 更好. 在这个人群中,DOAC与血栓栓塞和出血事件的风险较低有关.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 抗凝疗法是一种抗凝疗法.
背景情况:
- 过导管大动脉置换 (TAVR) 是对大动脉狭窄的常见手术.
- 在TAVR后心房动 (AF) 患者的最佳抗凝剂尚不清楚.
- 这项研究调查了抗凝剂选择对AF患者TAVR结果的影响.
研究的目的:
- 为了比较直接口服抗凝剂 (DOACs) 与维生素K对抗剂 (VKAs) 在TAVR后AF患者的结果.
- 评估抗凝剂选择与血栓栓塞事件和重大出血之间的关联.
- 为指导TAVR后抗凝剂治疗提供现实世界的证据.
主要方法:
- 对接受TAVR的AF患者的回顾性分析.
- 在TAVR后3个月被分为DOAC或VKA组的患者.
- 倾向性得分匹配用于组间比较结果 (血栓栓塞,出血).
主要成果:
- 与DOAC相比,使用维生素K抗剂 (VKA) 与较高的血栓栓塞事件 (HR 1.46) 和出血事件 (HR 1.21) 的风险有关.
- 匹配前的分析显示,DOAC组的血栓栓塞和出血率较低.
- 这项研究包括超过10,000名患有AF史的患者,在TAVR后接受抗凝药.
结论:
- 在TAVR后的AF患者中,直接口服抗凝剂 (DOAC) 治疗似乎是一个比维生素K抗剂 (VKA) 更安全,更有效的选择.
- 研究结果表明,对于这一患者群体来说,DOAC可能会在现实临床实践中被优先考虑.
- 进一步的研究可能会探索特定的DOAC剂和长期结果.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
01:25Aortic Regurgitation III: Medical Management
53
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53
01:22Aneurysm IV: Nursing Management
23
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
23